• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性大麻素摄取新抑制剂的设计、合成及生物学评价:与对脂肪酸酰胺水解酶的作用比较

Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.

作者信息

López-Rodríguez María L, Viso Alma, Ortega-Gutiérrez Silvia, Fowler Christopher J, Tiger Gunnar, de Lago Eva, Fernández-Ruiz Javier, Ramos José A

机构信息

Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense, E-28040 Madrid, Spain.

出版信息

J Med Chem. 2003 Apr 10;46(8):1512-22. doi: 10.1021/jm0210818.

DOI:10.1021/jm0210818
PMID:12672252
Abstract

A new series of arachidonic acid derivatives were synthesized and evaluated as inhibitors of the endocannabinoid uptake. Most of them are able to inhibit anandamide uptake with IC(50) values in the low micromolar range (IC(50) = 0.8-24 microM). In general, the compounds had only weak effects upon CB(1), CB(2), and VR(1) receptors (K(i) > 1000-10000 nM). In addition, there was no obvious relationship between the abilities of the compounds to affect anandamide uptake and to inhibit anandamide metabolism by fatty acid amidohydrolase (FAAH; IC(50) = 30-113 microM). This indicates that the compounds do not exert their effects secondarily to FAAH inhibition. It is hoped that these compounds, particularly the most potent in this series (compound 5, UCM707, with IC(50) values for anandamide uptake and FAAH of 0.8 and 30 microM, respectively), will provide useful tools for the elucidation of the role of the anandamide transporter system in vivo.

摘要

合成了一系列新的花生四烯酸衍生物,并对其作为内源性大麻素摄取抑制剂进行了评估。它们中的大多数能够抑制花生四烯乙醇胺摄取,IC(50)值处于低微摩尔范围(IC(50)=0.8 - 24 microM)。一般来说,这些化合物对CB(1)、CB(2)和VR(1)受体只有微弱作用(K(i)>1000 - 10000 nM)。此外,化合物影响花生四烯乙醇胺摄取的能力与抑制脂肪酸酰胺水解酶(FAAH;IC(50)=30 - 113 microM)催化花生四烯乙醇胺代谢的能力之间没有明显关系。这表明这些化合物并非通过抑制FAAH而间接发挥作用。希望这些化合物,特别是该系列中最有效的化合物(化合物5,UCM707,花生四烯乙醇胺摄取和FAAH的IC(50)值分别为0.8和30 microM),将为阐明花生四烯乙醇胺转运体系统在体内的作用提供有用工具。

相似文献

1
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.内源性大麻素摄取新抑制剂的设计、合成及生物学评价:与对脂肪酸酰胺水解酶的作用比较
J Med Chem. 2003 Apr 10;46(8):1512-22. doi: 10.1021/jm0210818.
2
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.新型花生四烯酸衍生物作为高效且选择性内源性大麻素转运体抑制剂的设计、合成及生物学评价
J Med Chem. 2001 Dec 20;44(26):4505-8. doi: 10.1021/jm015545y.
3
Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.N-棕榈酰乙醇胺中乙醇胺头部的修饰:干扰花生四烯酸乙醇胺代谢的新型药物的合成与评价
J Med Chem. 2003 Apr 10;46(8):1440-8. doi: 10.1021/jm0209679.
4
N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.N-酰基多巴胺:新型合成CB(1)大麻素受体配体及体外和体内具有大麻模拟活性的花生四烯乙醇胺失活抑制剂。
Biochem J. 2000 Nov 1;351 Pt 3(Pt 3):817-24.
5
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.内源性大麻素与大麻素受体、花生四烯乙醇胺转运体及脂肪酸酰胺水解酶相互作用的构象要求。
Chem Phys Lipids. 2000 Nov;108(1-2):15-35. doi: 10.1016/s0009-3084(00)00185-7.
6
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.棕榈酰乙醇胺的同系物和类似物对内源性大麻素花生四烯乙醇胺失活的影响。
Br J Pharmacol. 2001 Aug;133(8):1263-75. doi: 10.1038/sj.bjp.0704199.
7
Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.内源性大麻素转运体和脂肪酸酰胺水解酶抑制剂的药理学特性
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23. doi: 10.1007/s10571-006-9072-6. Epub 2006 May 31.
8
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.花生四烯酸乙醇胺摄取抑制剂VDM11对脂肪酸酰胺水解酶和单酰甘油脂肪酶的抑制作用:VDM11作为脂肪酸酰胺水解酶底物的证据。
Br J Pharmacol. 2005 Aug;145(7):885-93. doi: 10.1038/sj.bjp.0706253.
9
Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.脂肪酸磺酰氟抑制花生四烯乙醇胺代谢并与大麻素受体结合。
Biochem Biophys Res Commun. 1997 Feb 3;231(1):217-21. doi: 10.1006/bbrc.1997.6072.
10
Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.新型内源性大麻素转运体抑制剂的设计、合成及生物学评价
Eur J Med Chem. 2003 Apr;38(4):403-12. doi: 10.1016/s0223-5234(03)00045-x.

引用本文的文献

1
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.内源性大麻素系统作为治疗靶点的利弊:30 年的经验教训。
Pharmacol Rev. 2023 Sep;75(5):885-958. doi: 10.1124/pharmrev.122.000600. Epub 2023 May 10.
2
Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437.化学蛋白质组学揭示了大麻素再摄取抑制剂 WOBE437 的非靶标。
ACS Chem Biol. 2022 May 20;17(5):1174-1183. doi: 10.1021/acschembio.2c00122. Epub 2022 Apr 28.
3
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication.
减轻人乙醚 - 去极化激活的钾离子通道(hERG)抑制作用:口服生物可利用的CCR5拮抗剂作为R5型HIV-1复制强效抑制剂的设计
ACS Med Chem Lett. 2012 Jan 25;3(3):216-21. doi: 10.1021/ml2002604. eCollection 2012 Mar 8.
4
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking.AM404 可减弱由尼古丁相关线索和尼古丁引发的觅药行为复燃,但不影响尼古丁和食物摄取。
J Psychopharmacol. 2013 Jun;27(6):564-71. doi: 10.1177/0269881113477710. Epub 2013 Feb 20.
5
A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.酒精与内源性大麻素系统相互作用的综述:对酒精依赖的影响及未来研究方向。
Alcohol. 2012 May;46(3):185-204. doi: 10.1016/j.alcohol.2012.01.002. Epub 2012 Mar 27.
6
The endocannabinoid system as a target for the treatment of cannabis dependence.内源性大麻素系统作为治疗大麻依赖的靶点。
Neuropharmacology. 2009;56 Suppl 1(Suppl 1):235-43. doi: 10.1016/j.neuropharm.2008.07.018. Epub 2008 Jul 19.
7
The pharmacology of the cannabinoid system--a question of efficacy and selectivity.大麻素系统的药理学——疗效与选择性问题。
Mol Neurobiol. 2007 Aug;36(1):15-25. doi: 10.1007/s12035-007-0001-6. Epub 2007 Jul 7.
8
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.内源性大麻素信号增强与抑郁症的药物治疗
Pharmacol Res. 2007 Nov;56(5):360-6. doi: 10.1016/j.phrs.2007.09.003. Epub 2007 Sep 11.
9
Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.小脑颗粒神经元中花生四烯酸乙醇胺蓄积抑制剂的研究:与脂肪酸酰胺水解酶抑制作用的比较。
J Mol Neurosci. 2007 Sep;33(1):18-24. doi: 10.1007/s12031-007-0045-0.
10
The complications of promiscuity: endocannabinoid action and metabolism.滥交的并发症:内源性大麻素的作用与代谢
Br J Pharmacol. 2007 Nov;152(5):602-23. doi: 10.1038/sj.bjp.0707456. Epub 2007 Sep 17.